Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Clinical Trial ID NCT00096148

PubWeight™ 0.76‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00096148

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Target Therapy in Hematological Malignances: New Monoclonal Antibodies. Int Sch Res Notices 2014 0.76
Next 100